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Abstract: Magnetic nanoparticles (MNPs) have been proposed for targeted or embolization 
therapeutics. How MNP retention occurs in circulation may critically determine local 
hemodynamics, tissue distribution of MNPs, and the therapeutic effects. We attempted to 
establish a microcirculation model to study the magnetic capture of MNPs in small vessels and 
to determine the factors affecting MNP retention. Two-dimensional hemodynamic changes in 
response to magnet-induced MNP retention in the microvessels of the cremaster muscle in vivo 
were observed in a real-time manner using a laser speckle imaging technique. Changes in 
tissue perfusion of the cremaster muscle appeared to be closely correlated with the location 
of the magnet placement underneath the muscle in response to intra-arterial administration of 
dextran-coated MNPs. Magnet-related retention was observed along the edge of the magnet, 
as corroborated by the results of histology analysis and microcomputed tomography. In these 
preparations, tissue iron content almost doubled, as revealed by inductively coupled plasma 
optical emission spectroscopy. In addition, MNP retention was associated with reduced 
downstream flow in a dose-dependent manner. Dissipation of MNPs (5 mg/kg) occurred shortly 
after removal of the magnet, which was associated with significant recovery of tissue flow. 
However, MNP dissipation did not easily occur after administration of a higher MNP dose 
(10 mg/kg) or prolonged exposure to the magnetic field. An ultrasound after removal of the 
magnet may induce the partial dispersion of MNPs and thus partially improve hemodynamics. 
In conclusion, our results revealed the important correlation of local MNP retention and 
hemodynamic changes in microcirculation, which can be crucial in the application of MNPs 
for effective targeted therapeutics.
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Introduction
Magnetic targeting of therapeutic agents to specific sites in the body is advantageous 
in that the targeted drugs can be guided to and concentrated at the target area with 
limited systemic side effects.1,2 Magnetic nanoparticles (MNPs) with a magnetite core 
and organic polymer coating are often used as a drug carrier for this purpose.2,3 The 
MNPs, with characteristics of superparamagnetic magnetization, allow tracking under 
a magnetic field gradient and maintain stable colloidal suspensions.2 These MNPs and 
the drugs used in magnetic targeting are formulated into a pharmacologically stable 
composite that is injected into the circulation system and held in position at the target 
region against hemodynamic force by an external magnetic field.4–13
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Chemotherapeutic agents are the most studied category 
of drugs in magnetic targeted delivery to solid tumors in ani-
mal models4,7–9,12 and in humans,10,11,13 primarily due to their 
highly toxic nature. However, the therapeutic effects vary; 
this greatly depends on whether the magnetic targeting can 
be reproducibly achieved. Histological studies have revealed 
that local retention of MNPs in the tumor vessel or interstitial 
space of a tumor occur with magnetic targeting,4,9,14–16 partly 
due to magnetic targeting and partly due to the enhanced 
permeability and retention effect of leaky vessels in tumors. 
More 123I-labeled MNPs have been detected around tumor 
areas with an external magnet than with no magnet.17 Local 
retention of magnetic liposomes has also been demonstrated 
in the cranial microvessels of mice using a laser-scanning 
confocal fluorescence microscope.18 In addition, active target-
ing with magnetic guidance is required for the MNP-drug to 
exert its anti-tumor effect,4,19 implicating the effectiveness 
of magnetic targeting and its therapeutic potential. Although 
the response of MNPs in microvessels to external magnets 
working against hemodynamics has been simulated,20–22 their 
behavior in microvessels in vivo has not been well studied.
MNP administration may cause mechanical occlusion, 
or embolization, of capillaries under the influence of a mag-
netic field, as demonstrated in simulated vessels in vitro.20,21 
Although embolization therapy with MNPs has been tested in 
the treatment of solid tumors in animal models, presumably 
by reducing blood supply to the tumors,10,15,23 an effective 
reduction of blood flow in response to MNP administration 
has not been demonstrated in vivo. In contrast, vascular 
occlusion may hinder the targeted delivery of drugs using 
MNPs as carriers; therefore, conditions causing vascular 
occlusion should be avoided in such an application. Thus, 
the dose of MNPs and the rate of administration may exert 
a profound effect on hemodynamics and consequently on 
therapeutic effects.
MNPs are generally well tolerated with the dose studied 
in vivo.6,10,11,24 In animal studies, normal blood pressure, 
heart rate, and respiratory rate in response to intravenous 
injection of MNPs was observed;15 after administration 
of MNPs, hemodynamic responses to vasoconstrictors or 
dilators appeared to be unaltered.15,25 However, irreversible 
magnetic clustering may occur in response to a long enough 
exposure to a magnetic field, leading to vascular diameter/
hemodynamic changes.15 Although MNPs are generally 
considered superparamagnetic in water, blood components 
such as plasma proteins may form corona that greatly affect 
the surface characteristics of the particles in circulation,26 
allowing the formation of agglomerates in the magnetic field. 
To our knowledge, the retention and dispersion of MNPs in 
microvessels in response to magnetic guidance has not been 
investigated in vivo.
In this study, we determined the MNP retention profile 
around a permanent magnet we applied and asked whether 
MNP retention may affect hemodynamics in the microcircula-
tion of the cremaster muscle. Unlike leaky vessels in tumors, 
normal, intact microvessels in this preparation allow the direct 
effect of magnet application on MNP distribution in micro-
circulation to be determined. Although the cremaster muscle 
preparation has been suggested as an ideal model to visualize 
the effects of a magnetic field on the distribution kinetics of 
MNPs,15 the traditional setup requires light to pass through 
the muscle layer for visualization, which hinders the applica-
tion of a constant magnetic field. The laser speckle perfusion 
imaging technique used in this study allows the demonstration 
of two-dimensional real-time changes of tissue perfusion with 
a magnet placed underneath the muscle. Such techniques have 
been used to study tissue blood flow since 1982,6,27,28 but to 
our knowledge, have not been used to determine the effects of 
MNP retention in microcirculation. Our results demonstrated 
a close correlation of the magnetic field, MNP deposits, and 
hemodynamics in cremaster microcirculation.
Materials and methods
Materials
An MNP with magnetite embedded in a dextran matrix 
(Nanomag® D-COOH, 250 nm; 10 mg/mL), provided 
as a stable aqueous colloid, was purchased from Micro-
mod Partikeltechnologie GmbH (Rostock, Germany). 
  Neodymium (NdFeB) magnets were purchased from New 
Favor Industry Co, Ltd (Taiwan). Inactin® (sodium salt of 
ethyl-[1-methyl-propyl]-malonyl-thio-urea) and heparin 
(50,000 unit), were purchased from Sigma (St Louis, MO, 
USA). Hydroxyethyl starch solution (6%, HAES-steril®) was 
purchased from Fresenius Kabi (Germany).
Characterization of MNP
The particle size was determined by Backman Coulter (N4 
plus, Fullerton, CA, USA). The zeta potential of the MNP 
(Nanomag® D-COOH; 1 mg/mL, diluted with distilled water) 
was measured by a Zetasizer (Malvern ZA90, Worcestershire, 
UK) at 25°C.
Cremaster muscle preparation
A rat cremaster microcirculatory preparation was modified 
from a previously described method.29 The protocol was approved 
by the Institutional Animal Care and Use Committee. Briefly, 
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Sprague Dawley rats (346 ± 7 g, n = 27) were anesthetized using 
an intraperitoneal injection of Inactin (100 mg/kg), followed by 
a tracheostomy and cannulation of the carotid artery to measure 
blood pressure. The hair on the lower abdomen and around the 
scrotum was removed. A rectal temperature probe was inserted 
to monitor core body temperature, which was maintained at 
37°C ± 1°C. The urinary bladder was cannulated to ensure 
a patent urine flow. The cremaster muscle layers on both 
sides were separated with a bipolar cautery (Union Medical, 
UM-D30, FL) and the testis was removed. The left iliac artery 
was cannulated from the left femoral artery in a retrograde 
manner with PE50 tubing, without interrupting the blood flow 
to the pudic epigastric artery, a branch of the iliac artery that 
supplies blood to the cremaster bed (Figure 1A). The right iliac 
artery was left untouched, allowing the right cremaster muscle 
to serve as a control. Two small branches of the left iliac artery 
close to the origin of the pudic epigastric artery were ligated to 
ensure that most of the injected MNPs reached the cremaster 
vessels. A mixture of saline and hydroxyethyl starch (1:2) at a 
rate of 30 µL/minute was continuously infused via a catheter 
in order to maintain a patent catheter for the injection of MNPs 
(Nanomag® D-COOH; 250 nm, Micromod, Germany). Three 
to five traction stitches were placed through the distal tip and 
lateral sides of the cremaster to expose the terminal branches 
of the microcirculation (Figure 1B). The cremaster muscle 
was then spread on a homemade stage with a cylindrical 
NdFeB magnet (2.9 kGauss, with a radius of 9 mm and a 
height of 5 mm) placed underneath the left cremaster muscle 
(  Figure 1A), allowing removal of the magnet from below 
the stage without touching the muscle layer. The maximal 
magnetic field measured approximately 2.9 kGauss at 5 mm 
from the center of the magnet (Figure 1C). The muscle layer 
was continuously superfused with saline during the experiment. 
After equilibration, accumulative doses (up to ∼80 µL total) 
of MNPs were injected via an injection port of the arterial 
cannula.
Tissue flow measurement
The red blood cell velocity/tissue flow of the cremaster 
muscle was measured with a laser perfusion imager (Moor-
FLPI, Moor Instruments, England) in a noncontact manner 
with high spatial and temporal resolution. The setup using 
a laser diode for illumination provides full field perfusion 
maps of the cremaster muscle and allows quantification of 
the arbitrary regions of interest in the left (+MNP) vs right 
(control) muscle pieces. In addition, simultaneous photos 
of the preparation using a conventional charge-coupled 
device camera allow recording of the shape of the muscle 
piece with anatomical and morphological details, as well 
as major sites of MNP deposits in the vessels of the muscle 
pieces. Tissue perfusion was measured in a real-time manner 
and analyzed using MoorFLPI software (version 3.0) and 
expressed as two-dimensional distributions of hemodynam-
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Figure 1 Rat cremaster muscle preparation for magnetic nanoparticle retention and 
hemodynamic assessment. Magnetic nanoparticles were injected into the perfusion 
line that was cannulated into the left femoral artery in a retrograde manner, reaching 
the pudic epigastric artery, the branch supplying blood to the left cremaster muscle. 
A neodymium magnet with a radius of 9 mm was placed underneath the dissected 
muscle layer on the left, as depicted with a dotted circle, for magnetic nanoparticle 
capture (A). The image of the muscle pieces of a representative rat was taken using 
a digital camera (B). The magnetic field of the magnet was measured with a Gauss 
meter and plotted as a function of distance from the center of the magnet (C).
Note: The tip of the probe of the Gauss meter was placed 0, 1, 2, and 3 mm from 
the surface along the axial direction of the cylindrical magnet, as indicated.
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ics with pseudo-color and percentages of baseline values of 
entire or partial muscle pieces. In some experiments, % bin 
distribution analysis was performed to illustrate quantitative 
minor changes of the representative muscle piece. At the end 
of the experiment, the cremaster muscle was harvested after 
ligation at the base to stop the flow in the artery and vein 
simultaneously; it was then fixed with paraformaldehyde for 
further analysis. Histological analysis was conducted with 
the iron of the magnetite stained with Prussian blue, as pre-
viously described.25 In some experiments, the muscle layer 
was weighed, frozen, and stored under -20°C for quantitative 
analysis of iron in the tissue.
X-ray tomography
A commercial microcomputed tomography (CT) scanner 
(SkyScan 1076, Kontich, Belgium) was used in our imag-
ing analysis. SkyScan 1076 is a high-performance micro CT 
imaging system dedicated to small animal research. An opti-
cal charge-coupled device is connected to the system as the 
photon detector. The sealed x-ray tube generates polychro-
matic x-ray beams with energies from 20–100 kVp. Various 
options of spatial resolution in reconstruction images can be 
selected. The whole imager is housed in a radiation-shielded 
desktop unit. High-quality images are reconstructed with a 
high-speed computing system. Cremaster muscle tissue was 
fixed and stored in paraformaldehyde following the animal 
experiments. All images were acquired using the settings of 
50 kVp and 35 µm in spatial resolution. To better display 
the nanoparticle localization and circulatory distribution 
within the cremaster muscle, a maximum intensity projec-
tion technique was used to create the volumetric images for 
three-dimensional visualization.
Quantitative analysis of MNP retention  
in cremaster muscle
The cremaster muscle was dried at 80°C with a vacuum oven 
for 48 hours, followed by acid digestion using a Multiwave 
3000 microwave digestion system (Anton Paar; Austria). The 
iron content of the samples was measured using an Optima 
2100 DV inductively coupled plasma optical emission spec-
troscopy system (PerkinElmer, USA).
MNP dispersion with ultrasound
Using a commercially available machine (Sonitron 2000; 
Richmar, Inola, OK, USA; center frequency = 1 MHz) with 
a 10 mm unfocused probe and coupling gel, ultrasound was 
irradiated directly to the cremaster bed. Ultrasound exposure 
was set to a frequency of 1.0 MHz, a duty cycle of 20%, 
a pulse repetition frequency of 20 Hz, and an exposure time of 
5 minutes. The exposures began 20 minutes after the removal 
of the magnet to enhance the dispersion of the MNP pellets 
in the microvessels of the left cremaster muscle. The pressure 
at the cremaster bed was measured to be 0.59 MPa using a 
calibrated polyvinylidene difluoride needle-type hydrophone 
(Onda, Sunnyvale, CA; calibration range: 50 k to 20 MHz), 
which was equivalent to the spatial-peak temporal-average 
intensity (ISPTA) of 1.05 W/cm2.
Statistical analysis
Data are presented as mean ± SE and were analyzed using 
a student’s t-test or ANOVA with repeated time design fol-
lowed by a Duncan’s post hoc test. Statistical significance 
was determined as P , 0.05.
Results
The diameter of dextran-coated MNP was determined to be 
264 ± 6 nm (n = 3) by dynamic light scattering; electropho-
retic mobility measurements of the MNPs gave a highly nega-
tive zeta potential of -40.1 ± 0.3 mV at a pH of 7.9 (n = 3). 
To determine whether an NdFeB magnet of 2.9 kGauss may 
cause effective MNP retention and attenuation of blood flow 
in cremaster skeletal muscle microcirculation (Figure 1), a 
laser perfusion imager was used to measure the change of 
tissue blood flow in response to intra-arterial administration 
of MNPs.
Figure 2A shows images of representative cremaster 
skeletal muscle preparation in response to accumulative 
doses of MNPs, with the magnet placed underneath the 
left cremaster muscle piece. The pattern of MNP retention 
appears to be closely associated with the margin of the magnet 
placed underneath and may occur upstream or downstream 
of the magnet, but not in the middle, as indicated by the 
arrowheads. The simultaneous recordings of flux and photo 
images reveal correlated patterns of flow distribution and 
MNP retention in the left cremaster muscle preparation. MNP 
administration and retention caused attenuation of blood flow 
in the left, but not the right, cremaster muscle compared to 
that prior to MNP administration. No obvious change in 
flow was observed in the absence of the magnet (not shown). 
MNPs at 1, 5, and 10 mg/kg reduced the perfusion flow by 
90%, 44%, and 30%, respectively. Prolonged MNP retention 
(p in Figure 2A), recorded 17 minutes after administration 
of MNPs of 10 mg/kg, further reduced the perfusion to 
26% of the basal level. For this rat, continuous recordings 
of blood pressure and averaged levels of the perfusion flow 
are shown in Figure 2B. During the experimental period, the 
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
2820
Ma et alInternational Journal of Nanomedicine 2012:7
blood pressure and overall blood flow in the right cremaster 
muscle remained stable with time, whereas blood flow in 
the left cremaster muscle decreased with accumulative 
administration of MNPs in the presence of the magnet. The 
effect of MNP retention on the perfusion flow is summarized 
in Figure 2C. MNPs at both 5 and 10 mg/kg significantly 
reduced basal blood flow by 19% and 47%, respectively 
(n = 5, P , 0.05). Similar results were obtained when MNPs 
were administered with 0.5% bovine serum albumin (n = 8, 
data not shown), suggesting a minor change in the plasma 
protein composition may not alter the pattern of MNP 
behavior in response to a magnetic field.
Figure 3 illustrates MNP retention via a variety of 
methods. Histological analysis with Prussian blue staining 
demonstrated MNP retention in multiple microvessels of a 
representative left cremaster muscle preparation subjected 
to accumulative 10 mg/kg doses of MNP (Figure 3A). 
In Figure 3B, MNP distribution patterns in the cremaster 
muscle preparation of a representative rat are shown with 
flux, photo, and micro-CT images. In the rat presented 
in the upper panel of Figure 3B, the magnet underneath 
the muscle piece caused MNP retention around the edge 
of the magnet after administration of 10 mg/kg of MNP. 
The bright white spot in the micro-CT image on the right 
side of Figure 3B represents nanoparticle deposit, which 
is associated with the photo view. As a consequence of 
particle deposition in the microvessels of the left cremaster 
muscle, tissue perfusion was attenuated along the edge of 
the magnet and downstream by 69%; only an 18% reduc-
tion was observed in the right cremaster muscle. It is noted 
that the blood flow in the artery on the right side of the left 
cremaster muscle was preserved after MNP administration, 
suggesting that the flow in the artery on the right margin 
was not affected by the magnet. Quantitative analysis using 
inductively coupled plasma optical emission spectroscopy 
indicated that MNP administration with the magnet almost 
doubled tissue iron content in the left cremaster muscle 
piece (Figure 3C).
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Figure 2 Magnetic nanoparticles (MNPs) attenuated cremaster blood flow in a dose-dependent manner. Accumulative doses of MNPs (1, 5, and 10 mg/kg) were administered 
via the pudic epigastric artery feeding the left cremaster muscle with a magnet placed underneath. Laser speckle images (Flux) and photo images after each MNP dose or 
at the end of the experiment for prolonged (p) exposure in a representative rat are illustrated (A); continuous recordings of blood pressure (BP) and the tissue flow (flux; 
arbitrary unit PU) of the right (control) and the left (MNP) cremaster muscle of this rat are illustrated with time (B).
Notes: The arrowheads in the photo image of 5 mg/kg MNPs indicate two of the major sites of MNP deposit in vessels. The effect of cremaster flow is summarized as % basal 
flow (C; n = 5). *P , 0.05 compared with the basal value; #P , 0.05 compared with corresponding control value.
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Figure 4 illustrates local retention and dissipation of 
MNPs in microcirculation observed before and after mag-
net removal. Administration of MNPs (5 mg/kg) induced 
intravascular retention of MNPs in a narrow area along the 
circumference of the magnet placed underneath the muscle 
layer, as illustrated in the photo image, which was associated 
with a 42% reduction of tissue perfusion. Ten minutes after 
MNP administration, the magnet was removed. MNP dissi-
pation was observed almost immediately after removal of the 
magnet, as revealed by the photo image, which is associated 
with a partial recovery, ie, a 15% increase in tissue perfusion. 
The frequency analysis of the two-dimensional distribution 
of hemodynamic changes indicated an increase in the 
lowest perfusion area (the very left two bars in dark blue) 
of the left, but not right, cremaster muscle piece after MNP 
administration, presented as % bin; the lowest perfusion 
area was reduced more than 50% after magnet removal, 
suggesting improved perfusion. The summarized results 
indicate that total perfusion of the left cremaster muscle 
attenuated by 32% vs 37% after administration of 5 mg/kg 
of MNPs vs 10 mg/kg of MNPs (Figure 5). After magnet 
removal, left cremaster   perfusion increased by 34% in rats 
F
e
 
(
m
g
/
k
g
)
0
200
400
600
800
ControlM NP
᧦
Flux
right
Flux
left
Photo
left
Micro-CT
left 
B
C A
Figure 3 A magnetic field caused magnetic nanoparticle (MNP) retention in cremaster vasculature. In response to accumulative doses of MNPs (10 mg/kg; i.a.), MNP 
retention in the cremaster vasculature was demonstrated with Prussian blue staining (A). Both photo images and an image from a micro-CT scanner demonstrate MNP 
retention in the left cremaster muscle of a representative rat, which is associated with reduced tissue perfusion (B).
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with 5 mg/kg MNPs (P , 0.05). However, removal of the 
magnet did not cause significant recovery in tissue perfu-
sion in rats with 10 mg/kg MNPs (n = 8). In experiments 
with MNPs of 5 mg/kg, tissue perfusion analysis based on 
areas of upstream, on magnet and downstream suggested 
that tissue perfusion of only the area upstream of the mag-
net significantly increased in response to magnet removal 
(Figure 5B; P , 0.05).
In view of the results from Figures 4 and 5 indicating 
that removal of the magnet may not restore tissue perfusion, 
ultrasound was used to determine whether MNPs deposited in 
the microvessels may be better dispersed. Figure 6 illustrates 
that intra-arterial administration of MNPs (10 mg/kg) greatly 
reduced tissue perfusion by 27%. After 20 minutes, magnet 
removal did not restore tissue perfusion of the left cremaster 
muscle. However, ultrasound energy improved tissue perfu-
sion by 13%, which is associated with a minor reduction in 
the lowest perfusion area.
Discussion
We demonstrated that magnetic capture of MNPs in the 
microcirculation may take place at a relatively high local 
concentration. It is conceivable that MNPs may be captured in 
microvessels when the magnetic forces dominate the hemo-
dynamic force, as predicted with a simulated capillary.21,30 To 
our knowledge, the results are the first demonstration of the 
effect on blood flow of the in vivo administration of MNPs, 
which can be crucial in future applications. In addition, the 
pattern of MNP distribution may influence not only down-
stream hemodynamics, but also the efficacy of the pharma-
cological agent carried by MNPs in targeted therapy.
In this study, MNP retention associated with magnet 
placement has been demonstrated using different methods. 
The photo view of the laser speckle imager allows the 
observation and recording of MNP distribution patterns 
simultaneously with the flux view, which reveals hemo-
dynamic information based on red blood cell velocity in 
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Figure 4 Representative effects of magnet removal-induced MNP dissipation on tissue perfusion in cremaster muscle microcirculation.
Notes: Flux and photo views of both the left (L) vs right (R) cremaster muscle before (Basal) and after MNPs (+MNP; 5 mg/kg) administered to the left cremaster muscle with 
the magnet underneath the muscle piece are illustrated. Ten minutes after +MNP, the magnet was removed (-Mag); MNP dissipation was recorded approximately 30 minutes 
after removal of the magnet. Results of the frequency analysis of the perfusion map are illustrated as % bin in the right panel.
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a two-dimensional manner. The distinct patterns of MNP 
retention reveal strong correlation of the magnet placement 
and the structure of the vasculature. Since MNP retention 
occurred along the edge of the magnet, as in the photo view 
of the laser speckle imager (Figures 2A, 3B, and 4A) and 
micro-CT (Figure 3B), and even along the downstream edge 
of the magnet, as indicated by the lower arrowhead in Figure 
2A, it is anticipated that retention may occur in both arteries 
and veins. MNPs in the venous deposit might come from 
a branch upstream of the magnet, which runs through the 
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In contrast, MNP retention in the microvessels of cere-
bral circulation has been observed without any effect on 
hemodynamics.18 In treating tumors with magnetic targeting, 
intratumoral embolization by MNPs may10,15 or may not4 
occur. The discrepancy may be due to the dose administered. 
As higher doses of MNPs were administered in our study, 
blood flow in the cremaster muscle decreased sequentially 
(Figure 2), which supports the idea that mechanical occlu-
sion of tumor-feeding vessels may occur after administra-
tion of MNPs with high concentrations, causing necrosis 
and tumor remission.10 Although a static magnetic field 
per se may reduce red blood cell flow in capillaries,31 the 
magnetic field employed in the current study is much lower 
than the threshold in order for such an effect to occur in 
mammalian cells. Therefore, the flow reduction response to 
MNP administration is likely due to mechanical occlusion. 
This approach may serve as a strategy in the treatment of 
solid tumors on the body surface. However, in drug target-
ing, mechanical occlusion may hinder drug distribution in 
the target site downstream of the occlusion site. Therefore, 
appropriate doses of MNPs may be essential in targeted 
drug delivery.10
Although the superparamagnetic nature of the magne-
tite core and the highly negative zeta potential of particles 
usually allow dissipation and resuspension of MNPs after 
magnet removal in vitro,6 magnet removal did not ensure a 
quick dispersion of the MNP pellets in vivo, suggesting other 
factors in circulation, including salt, proteins, and blood cells, 
may alter the behavior of MNPs in blood vessels. This has 
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Figure 6 Ultrasound partially restored tissue perfusion of the left cremaster muscle 
after magnet removal.
Notes: Administration of MNPs (10 mg/kg; +MNP) was followed by magnet removal 
(-Mag) and application of ultrasound (+US) on the left (L) cremaster muscle piece, 
with the right (R) cremaster muscle as the control. Results of the frequency analysis 
of the perfusion map are illustrated as % bin in the right panel. These results are 
representative of four experiments.
area outside of that covered by the magnet, and might be 
captured in the venous system on the way back to the major 
vein (Figure 7). In this preparation, the veins often run in 
parallel with the arteries; therefore, MNP capture may occur 
in adjacent vessels (Figure 3A). We thus propose that MNP 
retention may occur in the arterial, capillary, and venous 
systems (Figure 7). Although the magnetic field decreased 
abruptly on the edge of the magnet, there is still 1 kGauss of 
magnetic energy at the edge (Figure 1C), which appears to be 
high enough to overcome flow-induced drag force to cause 
MNP deposit in these small vessels. However, magnetic field 
did exert limit, since the arteries close to but not influenced 
by the magnet preserved its perfusion (Figure 3B). Neverthe-
less, due to the direction of blood flow in this preparation, 
tissue perfusion downstream of the area influenced by the 
magnetic field (even away from the magnetic influence) was 
prone to decrease in response to MNP retention.
Figure 7 Schematic diagram of MNP retention along the edge of the magnet.
Notes: From left to right, MNP retention may occur in the lumen of the 2nd arteries, 
the major artery (in red), the capillaries, and the venules (in blue) in the cremaster 
muscle preparation. MNP deposit (in black) may occur at the margin of the magnet, 
which may completely or partially block flow in the microvessels. The lower part of 
the figure with the light background indicates the location of a neodymium magnet 
underneath the muscle layer.
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not really been addressed previously. In addition, a longer 
application of a magnetic field may facilitate the interaction 
between MNPs and thus make it more difficult for MNP 
dispersion to occur after magnet removal. Nevertheless, the 
application of ultrasound may be a safe way of MNP disper-
sion in vessels. To our knowledge, the results may be the first 
demonstration using ultrasound to induce MNP dispersion 
in vivo, even though the effect of the ultrasound was very 
limited. The coagulation cascade and/or an inflammatory 
response may be triggered by reduced flow after MNP reten-
tion, resulting in thrombosis and thus irreversible reduction 
of the flow that hinders recovery from magnet removal or 
ultrasound application.
Advanced micro-CT systems with high spatial resolu-
tion have been widely used in small animal experiments 
for quantitative imaging in recent years. In the current 
study, three-dimensional images of MNP distribution were 
acquired and reconstructed using a commercial micro-
CT scanner. Iron atoms in nanoparticles attenuate larger 
incident x-ray photons than soft tissue in the cremaster 
muscle. Consequently, a sharp contrast between MNPs 
and muscle tissue can be seen in micro-CT images where 
gray levels of nanoparticles are higher than the surrounding 
muscle tissues. Circulatory distribution patterns of MNPs 
shown in micro-CT images correspond to external magnet 
placement, as revealed by the photo images of the laser 
speckle imager. Therefore, micro-CT imaging may serve 
as an alternative way to demonstrate the local distribution 
of MNPs in vivo.
In the targeted delivery of MNP-drug, “passive targeting” 
by the enhanced permeability and retention effect may occur2 
as a consequence of the increased vascular permeability 
and defective lymphatic drainage that are often observed in 
tumors.32 Our results demonstrate that active targeting with 
magnetic guidance can be achieved in microcirculation, 
which may contribute, at least in part, to the local retention 
of MNPs observed around the target area in previous stud-
ies.4,14–16 The cremaster muscle preparation may serve as a 
microcirculation model to study the potential effects of the 
size or surface characteristics of MNPs in response to a 
magnetic field in vivo.
Conclusion
This study demonstrates that magnetic force may readily 
overcome hemodynamic force and cause vascular retention of 
MNPs in microcirculation. Magnet-induced MNP retention 
in microvessels may depend on the topography of magnetic 
field distribution, and may exert an effect on hemodynamics 
in a dose-dependent manner. Hemodynamics may be partially 
restored after the removal of the magnetic influence plus 
ultrasound application. It is likely that ischemia associated 
with the reduced flow may be of greater concern than the 
potential toxicity of MNPs at local sites.
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